Role of glycosaminoglycans in inflammation

Inflammopharmacology

Volumn 9, Issue 1-2, 2001, Pages 165-169

  Lever, R ^a   Smailbegovic, A ^a   Page, C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HISTAMINE;

ALLERGY; CELL ADHESION; CONFERENCE PAPER; DEGRANULATION; EXTRACELLULAR MATRIX; EXTRAVASATION; HISTAMINE RELEASE; HUMAN; INFLAMMATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034937128     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856001300248443     Document Type: Conference Paper

References (33)

1. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin
2. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: Evidence for cytokine dependence and detection of a novel sulfatase
3. Endothelial binding sites for heparin. Specificity and role in heparin neutralization
4. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions
5. Structure activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-Xa activity
6. Anticoagulant action of heparin
7. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18)
8. The use of heparin as an anti-inflammatory agent
9. Monocyte adhesion to activated aortic endothelium: Role of L-selectin and heparan sulfate proteoglycans
10. Heparins - Anionic polyelectrolyte drugs
11. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils
12. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins
13. Heparin releases heparan sulfate from the cell surface
14. The plasma contact system in atopic asthma
15. Heparin-like anticoagulants in asthma
16. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro
17. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules
18. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin
19. Extension and structural variability of the antithrombin-binding sequence in heparin
20. Disruption of sulphated glycosaminoglycans in intestinal inflammation
21. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate
22. Heparin attenuates TNF-alpha induced inflammatory response through a CD1 1b dependent mechanism
23. Urinary glycosaminoglycan levels are increased in acute severe asthma - A role for eosinophil-derived gelatinase B?
24. Effects of heparin and its desulfated derivatives on leukocyte-endothelial adhesion
25. GMP-140 binding to neutrophils is inhibited by sulfated glycans
26. Heparin increases the adhesion of human peripheral blood mononuclear cells to pre-stimulated human umbilical vein endothelial cells without upregulating adhesion molecule expression
27. Effects of heparin upon adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells and adhesion molecule expression in vitro
28. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides
29. Further characterisation of the antithrombin-binding sequence in heparin
30. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation
31. Inhibition of tumour metastasis by heparanase inhibiting species of heparin
32. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes
33. Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo